Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hersh

Showing results (81-90 of 572) with videos related to

Pageof 58
Sort By:
World Journal of Surgery|July 30, 1979
Combined modality therapy of malignant melanomaE M Hersh, J U Gutterman, C M McBride
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|August 9, 2017
Wellness and the Role of Comorbidities in Multiple SclerosisBrandon P Moss, Mary R Rensel, Carrie M Hersh
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|July 11, 2003
Feasibility to generate monocyte-derived dendritic cell from coculture with melanoma tumor cells in the presence of granulocyte/macrophage colony-stimulating factor (GM-CSF) and interleukin-4Young T Kim, Evan M Hersh, Katrina T Trevor
Journal of Interferon Research|January 1, 1982
Clinical and immunological study of beta interferon by intramuscular route in patients with metastatic breast cancerJ R Quesada, J U Gutterman, E M Hersh
Cancer Chemotherapy and Pharmacology|January 1, 1986
Clinical pharmacology of the biological response modifier maleic anhydride divinyl ether copolymer (MVE-2)M G Rosenblum, A M Rios, E M Hersh
BMJ Open|March 4, 2018
Do non-inferiority trials of reduced intensity therapies show reduced effects? A descriptive analysisScott K Aberegg, Andrew M Hersh, Matthew H Samore
Annual Review of Medicine|January 1, 1977
BCG as adjuvant immunotherapy for neoplasiaE M Hersh, J U Gutterman, G M Mavligit
Surgical Neurology|September 1, 1973
Primary brain tumors: tumor immunity and immunocompetenceG M Mavligit, J U Gutterman, E M Hersh
Cancer Treatment Reviews|March 1, 1974
Perspectives in immunotherapy of lung cancerE M Hersh, J U Gutterman, G M Mavligit
Cancer|November 15, 1980
Cellular immune modulation after a single high dose of Levamisole in patients with carcinomaU H Lewinski, G M Mavligit, E M Hersh
Pageof 58

Showing results (81-90 of 572) with videos related to

Sort By:
Pageof 58
World Journal of Surgery|July 30, 1979
Combined modality therapy of malignant melanomaE M Hersh, J U Gutterman, C M McBride
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|August 9, 2017
Wellness and the Role of Comorbidities in Multiple SclerosisBrandon P Moss, Mary R Rensel, Carrie M Hersh
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|July 11, 2003
Feasibility to generate monocyte-derived dendritic cell from coculture with melanoma tumor cells in the presence of granulocyte/macrophage colony-stimulating factor (GM-CSF) and interleukin-4Young T Kim, Evan M Hersh, Katrina T Trevor
Journal of Interferon Research|January 1, 1982
Clinical and immunological study of beta interferon by intramuscular route in patients with metastatic breast cancerJ R Quesada, J U Gutterman, E M Hersh
Cancer Chemotherapy and Pharmacology|January 1, 1986
Clinical pharmacology of the biological response modifier maleic anhydride divinyl ether copolymer (MVE-2)M G Rosenblum, A M Rios, E M Hersh
BMJ Open|March 4, 2018
Do non-inferiority trials of reduced intensity therapies show reduced effects? A descriptive analysisScott K Aberegg, Andrew M Hersh, Matthew H Samore
Annual Review of Medicine|January 1, 1977
BCG as adjuvant immunotherapy for neoplasiaE M Hersh, J U Gutterman, G M Mavligit
Surgical Neurology|September 1, 1973
Primary brain tumors: tumor immunity and immunocompetenceG M Mavligit, J U Gutterman, E M Hersh
Cancer Treatment Reviews|March 1, 1974
Perspectives in immunotherapy of lung cancerE M Hersh, J U Gutterman, G M Mavligit
Cancer|November 15, 1980
Cellular immune modulation after a single high dose of Levamisole in patients with carcinomaU H Lewinski, G M Mavligit, E M Hersh
Pageof 58